Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study
Erich Tusch, Joanne Reekie(University of Copenhagen), Justyna Kowalska(Medical University of Warsaw), Jörg Janne Vehreschild(University Hospital Cologne), Olaf Degen(Universität Hamburg), Antonella Castagna(Vita-Salute San Raffaele University), Josip Begovać(University of California San Diego), Robert Zangerle(Universität Innsbruck), Elmar Wallner(Landeskrankenhaus Feldkirch), Sofia Dos Santos Mendes(Merck & Co., Inc., Rahway, NJ, USA (United States)), Huldrych F. Günthard(University of Zurich), Charlotte Martin(Centre Hospitalier Universitaire de Saint-Pierre), Nadine Jaschinski(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Katharina Kusejko(University of Zurich), Cristina Mussini(University of Modena and Reggio Emilia), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Ferdinand W.N.M. Wit(Amsterdam UMC Location University of Amsterdam), Vani Vannappagari(ViiV Healthcare (Spain)), Lars Peters(University of Copenhagen), Lene Ryom(University of Copenhagen), Jim Rooney(Gilead Sciences (United States)), Joan Tallada
Cited by 1
Related Papers
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k